Keep up to date with the latest news and articles from Genome Biology and BioMed Central.
David Secko
Correspondence: David Secko dmsecko@interchange.ubc.ca
Genome Biology 2003, 4:spotlight-20030925-01 doi:10.1186/gb-spotlight-20030925-01
A ubiquitous antitumor drug target preferentially kills tumor cells due to target conformation
